Actividades asistenciales

ANTICANCER COMBINATION THERAPY
31/10/2025 - ABSTRACT The invention describes anti-cancer therapies comprising using an polypeptide capable of specifically binding to LRP5 and LRP6 in combination with an anti-PD1 antibody.